Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF

Eur Respir J. 2015 Oct;46(4):1217-21. doi: 10.1183/13993003.00584-2015. Epub 2015 Sep 4.

¹ Dept of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, member of the German Center for Lung Research (DZL), Munich, Germany Katrin.Milger@med.uni-muenchen.de.
² Dept of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, member of the German Center for Lung Research (DZL), Munich, Germany.
³ Dept of Respiratory Medicine, Asklepios Clinic Gauting, Comprehensive Pneumology Center, member of the German Center for Lung Research (DZL), Munich, Germany.
⁴ Dept of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, member of the German Center for Lung Research (DZL), Munich, Germany Dept of Respiratory Medicine, Asklepios Clinic Gauting, Comprehensive Pneumology Center, member of the German Center for Lung Research (DZL), Munich, Germany.

No abstract available

Publication types